Harold Swerdlow

Harold Swerdlow

Auto-generated profile, based on publicly available information

Harold Swerdlow

Wellcome Trust Sanger Institute, Hinxton, UK

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2017 in Nature Methods
Verified
Journal Article
Open access
PDF file
MSMarlon Stoeckius
Marlon Stoeckius
CHChristoph Hafemeister
Christoph Hafemeister
WSWilliam Stephenson
William Stephenson
BHBrian Houck-Loomis
Brian Houck-Loomis
PCPratip K Chattopadhyay
Pratip K Chattopadhyay
PSPeter Smibert
Peter Smibert
Using established high-throughput single-cell RNA-seq platforms, CITE-seq combines highly multiplexed, antibody-based protein marker quantification with unbiased transcriptome profiling for thousands of single cells. High-throughput single-cell RNA sequencing has transformed our understanding of complex cell populations, but it does not provide phenotypic information such as cell-surface protein levels. Here, we describe cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq), a method in which oligonucleotide-labeled antibodies are used to integrate cellular protein and transcriptome measurements into an efficient, single-cell readout. CITE-seq is compatible with existing single-cell sequencing approaches and scales readily with throughput increases.

6 November 2008 in Nature
Verified
Journal Article
Open access
PDF file
DBDavid R. Bentley
David R. Bentley
SBShankar Balasubramanian
Shankar Balasubramanian
HSHarold P. Swerdlow
Harold P. Swerdlow
GSGeoffrey P. Smith
Geoffrey P. Smith
JMJohn Milton
John Milton
ASAnthony J. Smith
Anthony J. Smith
DNA sequence information underpins genetic research, enabling discoveries of important biological or medical benefit. Sequencing projects have traditionally used long (400–800 base pair) reads, but the existence of reference sequences for the human and many other genomes makes it possible to develop new, fast approaches to re-sequencing, whereby shorter reads are compared to a reference to identify intraspecies genetic variation. Here we report an approach that generates several billion bases of accurate nucleotide sequence per experiment at low cost. Single molecules of DNA are attached to a flat surface, amplified in situ and used as templates for synthetic sequencing with fluorescent reversible terminator deoxyribonucleotides. Images of the surface are analysed to generate high-quality sequence. We demonstrate application of this approach to human genome sequencing on flow-sorted X chromosomes and then scale the approach to determine the genome sequence of a male Yoruba from Ibadan, Nigeria. We build an accurate consensus sequence from >30× average depth of paired 35-base reads. We characterize four million single-nucleotide polymorphisms and four hundred thousand structural variants, many of which were previously unknown. Our approach is effective for accurate, rapid and economical whole-genome re-sequencing and many other biomedical applications.

1 January 2011 in Cell
Verified
Journal Article
Open access
PSPhilip J. Stephens
Philip J. Stephens
CGChris D. Greenman
Chris D. Greenman
BFBeiyuan Fu
Beiyuan Fu
FYFengtang Yang
Fengtang Yang
GBGraham R. Bignell
Graham R. Bignell
PCPeter J. Campbell
Peter J. Campbell
Cancer is driven by somatically acquired point mutations and chromosomal rearrangements, conventionally thought to accumulate gradually over time. Using next-generation sequencing, we characterize a phenomenon, which we term chromothripsis, whereby tens to hundreds of genomic rearrangements occur in a one-off cellular crisis. Rearrangements involving one or a few chromosomes crisscross back and forth across involved regions, generating frequent oscillations between two copy number states. These genomic hallmarks are highly improbable if rearrangements accumulate over time and instead imply that nearly all occur during a single cellular catastrophe. The stamp of chromothripsis can be seen in at least 2%-3% of all cancers, across many subtypes, and is present in ∼25% of bone cancers. We find that one, or indeed more than one, cancer-causing lesion can emerge out of the genomic crisis. This phenomenon has important implications for the origins of genomic remodeling and temporal emergence of cancer.

1 January 2012 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MQMichael Quail
Michael Quail
MSMiriam E Smith
Miriam E Smith
PCPaul Coupland
Paul Coupland
TOThomas D Otto
Thomas D Otto
SHSimon R Harris
Simon R Harris
YGYong Gu
Yong Gu
Next generation sequencing (NGS) technology has revolutionized genomic and genetic research. The pace of change in this area is rapid with three major new sequencing platforms having been released in 2011: Ion Torrent’s PGM, Pacific Biosciences’ RS and the Illumina MiSeq. Here we compare the results obtained with those platforms to the performance of the Illumina HiSeq, the current market leader. In order to compare these platforms, and get sufficient coverage depth to allow meaningful analysis, we have sequenced a set of 4 microbial genomes with mean GC content ranging from 19.3 to 67.7%. Together, these represent a comprehensive range of genome content. Here we report our analysis of that sequence data in terms of coverage distribution, bias, GC distribution, variant detection and accuracy. Sequence generated by Ion Torrent, MiSeq and Pacific Biosciences technologies displays near perfect coverage behaviour on GC-rich, neutral and moderately AT-rich genomes, but a profound bias was observed upon sequencing the extremely AT-rich genome of Plasmodium falciparum on the PGM, resulting in no coverage for approximately 30% of the genome. We analysed the ability to call variants from each platform and found that we could call slightly more variants from Ion Torrent data compared to MiSeq data, but at the expense of a higher false positive rate. Variant calling from Pacific Biosciences data was possible but higher coverage depth was required. Context specific errors were observed in both PGM and MiSeq data, but not in that from the Pacific Biosciences platform. All three fast turnaround sequencers evaluated here were able to generate usable sequence. However there are key differences between the quality of that data and the applications it will support.

27 October 2010 in Nature
Verified
Journal Article
Closed access
PDF file
PCPeter J. Campbell
Peter J. Campbell
SYShinichi Yachida
Shinichi Yachida
LMLaura J. Mudie
Laura J. Mudie
PSPhilip J. Stephens
Philip J. Stephens
EPErin D. Pleasance
Erin D. Pleasance
PFP. Andrew Futreal
P. Andrew Futreal

1 January 2012 in BMC Genomics
Verified
Journal Article
Open access
PDF file
SOSamuel Oyola
Samuel Oyola
TOThomas D Otto
Thomas D Otto
YGYong Gu
Yong Gu
GMGareth Maslen
Gareth Maslen
MMMagnus Manske
Magnus Manske
MQMichael A Quail
Michael A Quail
Massively parallel sequencing technology is revolutionizing approaches to genomic and genetic research. Since its advent, the scale and efficiency of Next-Generation Sequencing (NGS) has rapidly improved. In spite of this success, sequencing genomes or genomic regions with extremely biased base composition is still a great challenge to the currently available NGS platforms. The genomes of some important pathogenic organisms like Plasmodium falciparum (high AT content) and Mycobacterium tuberculosis (high GC content) display extremes of base composition. The standard library preparation procedures that employ PCR amplification have been shown to cause uneven read coverage particularly across AT and GC rich regions, leading to problems in genome assembly and variation analyses. Alternative library-preparation approaches that omit PCR amplification require large quantities of starting material and hence are not suitable for small amounts of DNA/RNA such as those from clinical isolates. We have developed and optimized library-preparation procedures suitable for low quantity starting material and tolerant to extremely high AT content sequences. We have used our optimized conditions in parallel with standard methods to prepare Illumina sequencing libraries from a non-clinical and a clinical isolate (containing ~53% host contamination). By analyzing and comparing the quality of sequence data generated, we show that our optimized conditions that involve a PCR additive (TMAC), produces amplified libraries with improved coverage of extremely AT-rich regions and reduced bias toward GC neutral templates. We have developed a robust and optimized Next-Generation Sequencing library amplification method suitable for extremely AT-rich genomes. The new amplification conditions significantly reduce bias and retain the complexity of either extremes of base composition. This development will greatly benefit sequencing clinical samples that often require amplification due to low mass of DNA starting material.